ARTICLE - PHARMACOKINETICS OF ECHINOCANDINS IN SPECIAL PATIENT POPULATIONS

Pharmacokinetics of echinocandins in neonates, children and adolescents, obese patients, patients with hepatic or renal impairment, critically ill patients (including burn patients) and patients with hematological diseases

22/05/2015 - This review provides up-to-date information on PK data of anidulafungin, caspofungin and micafungin in special patient populations. Patient populations addressed are neonates, children and adolescents, obese patients, patients with hepatic or renal impairment, critically ill patients (including burn patients) and patients with hematological diseases.

Impact of special patient populations on the pharmacokinetics of echinocandins

Muilwijk EW, Lempers VJ, Burger DM, Warris A, Pickkers P, Aarnoutse RE, Br├╝ggemann RJ.

Expert Rev Anti Infect Ther. 2015 Jun;13(6):799-815

Find this article here

RECENT NEWS | ARCHIVE